Ballast Inc’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,703
| Closed | -$248K | – | 122 |
|
|
2023
Q4 | $248K | Sell |
6,703
-101
| -1% | -$3.74K | 0.09% | 108 |
|
|
2023
Q3 | $247K | Sell |
6,804
-16,403
| -71% | -$595K | 0.1% | 102 |
|
|
2023
Q2 | $827K | Buy |
23,207
+1,844
| +9% | +$65.7K | 0.32% | 57 |
|
|
2023
Q1 | $760K | Buy |
21,363
+1,543
| +8% | +$54.9K | 0.31% | 60 |
|
|
2022
Q4 | $696K | Buy |
19,820
+1,695
| +9% | +$59.6K | 0.3% | 61 |
|
|
2022
Q3 | $533K | Buy |
18,125
+4,291
| +31% | +$126K | 0.26% | 64 |
|
|
2022
Q2 | $752K | Buy |
13,834
+26
| +0.2% | +$1.41K | 0.35% | 57 |
|
|
2022
Q1 | $751K | Buy |
13,808
+2,096
| +18% | +$114K | 0.29% | 63 |
|
|
2021
Q4 | $645K | Sell |
11,712
-101
| -0.9% | -$5.56K | 0.25% | 63 |
|
|
2021
Q3 | $564K | Buy |
11,813
+403
| +4% | +$19.2K | 0.24% | 58 |
|
|
2021
Q2 | $567K | Buy |
11,410
+2,518
| +28% | +$125K | 0.24% | 59 |
|
|
2021
Q1 | $396K | Buy |
8,892
+2,093
| +31% | +$93.2K | 0.19% | 64 |
|
|
2020
Q4 | $312K | Buy |
6,799
+275
| +4% | +$12.6K | 0.16% | 72 |
|
|
2020
Q3 | $306K | Sell |
6,524
-522
| -7% | -$24.5K | 0.17% | 74 |
|
|
2020
Q2 | $359K | Buy |
7,046
+129
| +2% | +$6.57K | 0.23% | 69 |
|
|
2020
Q1 | $327K | Buy |
6,917
+1,607
| +30% | +$76K | 0.23% | 68 |
|
|
2019
Q4 | $311K | Buy |
5,310
+724
| +16% | +$42.4K | 0.17% | 80 |
|
|
2019
Q3 | $247K | Hold |
4,586
| – | – | 0.15% | 89 |
|
|
2019
Q2 | $232K | Buy |
4,586
+99
| +2% | +$5.01K | 0.14% | 90 |
|
|
2019
Q1 | $234K | Buy |
+4,487
| New | +$234K | 0.15% | 87 |
|
|
2018
Q3 | – | Sell |
-3,946
| Closed | -$201K | – | 96 |
|
|
2018
Q2 | $201K | Buy |
+3,946
| New | +$201K | 0.16% | 86 |
|